Saturday, 31 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Hindustan Bio Sciences Merger & Restructuring

Hindustan Bio Sciences Ltd announced a capital reduction scheme to set off accumulated losses against its share capital. No cash consideration is paid to shareholders.

Source

BSE filing, NSE: HINDBIO. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Hindustan Bio Sciences Ltd: key numbers

Share price
₹6.68
Market cap
₹6.85 Cr
Revenue (annual)
₹0.74 Cr
Net profit (annual)
₹-0.08 Cr
P/E (TTM)
-33.2×Sector 45.9×
Promoter holding
12.19%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Hindustan Bio Sciences Ltd

All →

Other merger & restructuring announcements

All →